08:15-08:30 Vitallink symposium Session Room 2, 2F 
Vitallink symposium 
Moderator(s) Cheol Woong Jung (Korea), Curie Ahn (Korea)
08:15-08:20 Opening Remarks Curie Ahn (Korea) 
08:20-08:25 Congratulatory address I Nancy L. Ascher (USA ) 
08:25-08:30 Congratulatory address II Romina Danguilan (Philippines) 
 
08:30-09:30 Vitallink symposium 1 Session Room 2, 2F 
Translation of Transplantation Science into Clinic 
Moderator(s) Samuel Lee (Korea), Philip O'Connell (Australia)
08:30-08:45 Immunologic tools for transplantation research Eun-Suk Kang (Korea) 
08:45-09:00 Transplantation research using database and omics Jong Cheol Jeong (Korea) 
09:00-09:30 Publication tip Transplantation Journal Jeremy Chapman (Australia) 
 
09:30-10:00  Coffee break  
 
10:00-11:15 Vitallink symposium 2 Session Room 2, 2F 
Challenges in Deceased Organ Transplantation in Asia 
Moderator(s) Insung Moon (Korea), Dorjsuren Gantsetseg (Mongolia)
10:00-10:20 Revised Organ Donor Act in Mongolia: Legal issues Pandaan Batchuluun (Mongolia) 
10:20-10:35 Medical team participation & national team work building Khin Maung Htay (Myanmar) 
10:35-10:55 Strategy for building a sustaining public engagement in organ donation Kenneth Wong (Hong Kong) 
10:55-11:15 Challenges in deceased organ transplantation in Asia Philip O'Connell (Australia) 
 
11:15-12:30 Vitallink symposium 3 Session Room 2, 2F 
Update of DOI and ethical challenges in organ transplantation in Asia 
Moderator(s) Won-Hyun Cho (Korea), Hiroto Egawa (Japan)
11:15-11:35 Function and Activities of DOI, Past 10 years Nancy L. Ascher (USA ) 
11:35-11:55 Update of DOI - What is new? Dominique Martin (Australia) 
11:55-12:10 Responsibilities and perspectives of Asia toward Updated DOI Romina Danguilan (Philippines ) 
12:10-12:30 Panel discussion Hiroto Egawa (Japan)
Romina Danguilan (Philippines)
Harun Ur Rashid (Bangladesh)
 
 
11:15-12:15 KST sponsored research project Session Room 3, 2F 
2018 KST sponsored research project presentation 
Moderator(s) Hee Jung Wang (Korea), Oh Jung Kwon (Korea)
11:15-11:45 ½ÅÀåÀÌ½Ä È¯ÀÚÀÇ »ý°Ë Á¶Á÷¿¡¼­ Tissue-Resident NK ¼¼Æ÷°¡ ÀÌ½Ä ½ÅÀåÀÇ ¼¶À¯È­¿¡ ¹ÌÄ¡´Â ¿µÇâ ¿¬±¸ Sung Shin (Korea) 
11:45-12:15 Çѱ¹ ³ú»çÀÚ ½ÅÀåÀÌ½Ä ¼öÇýÀÚÀÇ ÀÌ½Ä ÈÄ ±â´ë¼ö¸í »êÃâ ¹× ÀÌ¿¡ ±â¹ÝÇÑ ³ú»çÀÚ ½ÅÀå ºÐ¹è ¹æ¾È Jaeseok Yang (Korea) 
 
12:30-13:30  Luncheon symposium 1 (GC Pharma) Session Room 2, 2F 
Moderator(s) Jae-Won Joh (Korea)
12:30-13:30 Hepatitis B Immunoglobulin Prophylaxis after Liver Transplantation Jong Man Kim (Korea) 
 
12:30-13:30  Luncheon symposium 2 (Sanofi Genzyme) Session Room 3, 2F 
Moderator(s) Sungjoo Kim (Korea)
12:30-13:30 The Role of Thymoglobuline induction in Kidney Transplantation Jae Berm Park (Korea) 
 
13:30-15:00 PG course 1 (Kidney) Session Room 2, 2F 
Preoperative donor and recipient evaluation 
Moderator(s) Eun-jee Oh (Korea), Robert Liwski (Canada)
13:30-14:00 Optimized HLA antibody testing in transplantation Robert Liwski (Canada) 
14:00-14:30 Detection and monitoring of ABO Ab in ABO incompatible transplant Dae-Hyun Ko ( Korea) 
14:30-15:00 Desensitization protocols in highly sensitized renal transplant Kyu Ha Huh ( Korea) 
 
13:30-15:00 PG course 2 (Basic) Session Room 3, 2F 
Analysis of signal transduction network in immune cells 
Moderator(s) Junho Chung (Korea), Hyori Kim (Korea)
13:30-14:00 Signal transduction in B cells Tae Jin Kim (Korea) 
14:00-14:30 Systems Biology Approach of signaling inside immune cells Sanghoon Ha (Korea) 
14:30-15:00 Cytokine signalling Kyungmoo Yea (Korea) 
 
13:30-15:30 PG course 3 (±³À°À§¿øȸ) Session Room 4, 2F 
»ýüÀå±â±¸µæÀÇ ¿ä·É°ú À§Çè: knack and pitfall in living donor Kidney and Liver procurement
(Surgical issue in living donor kidney and liver recovery) 
Moderator(s) Hee Chul Yu (Korea), Hyung Joon Ahn (Korea)
13:30-13:50 Hand assisted laparoscopic nephrectomy Myung-Ki Kim (Korea) 
13:50-14:10 Video assisted mini-laparotomy nephrectomy Woong Kyu Han (Korea) 
14:10-14:30 Totally laparoscopic nephrectomy Hyuk Jin Cho (Korea) 
Moderator(s) Chinburen Jigjidsunren (Mongolia), Chandra Bhati (India)
14:30-14:50 Open approach Je Ho Ryu (Korea) 
14:50-15:10 Laparoscopic approach Jong Man Kim (Korea) 
15:10-15:30 Robotic approach Gi Hong Choi (Korea) 
 
15:00-15:30  Coffee break  
 
15:30-17:00 PG course 4 (Kidney) Session Room 2, 2F 
Practical Issues in postoperative care  
Moderator(s) Sang-Oh Lee (Korea), Natavudh Townamchai (Thailand)
15:30-16:00 Monitoring for BK virus-associated nephropathy Jang-Hee Cho (Korea) 
16:00-16:30 Monitoring and prophylaxis of CMV infection after transplantation Sang-Oh Lee (Korea) 
16:30-17:00 Management of latent tuberculosis in transplantation Jaeseok Yang (Korea) 
 
15:30-17:00 PG course 5 (Liver) Session Room 3, 2F 
Management of surgical complications following liver transplantation 
Moderator(s) Hee Chul Yu (Korea), Toshimi Kaido (Japan)
15:30-15:48 Biliary complications Kenneth Chok (Hong Kong) 
15:48-16:06 Hepatic inflow complications Toshimi Kaido (Japan) 
16:06-16:24 Hepatic outflow complications Je Ho Ryu (Korea) 
16:24-16:42 Management of bleeding-related complication Hae Won Lee (Korea) 
16:42-17:00 Critical complications in liver donor Gi-won Song (Korea) 
 
15:30-17:00 PG course 6 (±³À°À§¿øȸ) Session Room 4, 2F 
Technical pitfall in Organ Transplantation 
Moderator(s) Dong Kwan Kim (Korea), Dong-Sik Kim (Korea)
15:30-15:48 Heart Yang Hyun Cho (Korea) 
15:48-16:06 Lung Jin Gu Lee (Korea) 
16:06-16:24 Kidney Young-nam Roh (Korea) 
16:24-16:42 Liver Ho Joong Choi (Korea) 
16:42-17:00 Pancreas Sung Shin (Korea) 
 
17:00-17:30  KST Board Meeting Session Room 2, 2F 
 
08:00-08:30  Opening ceremony Session Room 1, 1F 
 
08:30-09:30  Keynote lectures 1 Session Room 1, 1F 
Moderator(s) Soon-il Kim (Korea), Byung-Chang Kim (Korea)
08:30-09:00 Liver transplantation for hepatocellular carcinoma: the transplant benefit perspective Alessandro Vitale (Italy) 
09:00-09:30 Regulation of autoimmunity and anti-cancer immunity by inhibitory co-receptors Taku Okazaki (Japan) 
 
09:30-10:30  Plenary Session 1 (Best papers) Session Room 1, 1F 
Moderator(s) Jae-Won Joh (Korea), Yu Seun Kim (Korea)
09:30-09:45 Involvement of genetic variation and related gene expression changes on acute rejection in renal transplant recipients Hyeon Seok Hwang (Korea) 
09:45-10:00 New Onset Diabetes after Adult Liver Transplantation in The Korean Organ Transplantation Registry Study Jong Man Kim (Korea) 
10:00-10:15 Outcomes of donor lobectomy in cadaveric lung transplantation. Woo Sik Yu (Korea) 
10:15-10:30 The effects of anti-BAFF monoclonal antibody in the HLA-A2 sensitized mouse model Ji-Won Min (Korea) 
 
10:30-10:50  Coffee break  
 
10:50-12:20 Concurrent symposium 1 (Kidney) Session Room 2, 2F 
Immunologic management in kidney transplantation : A step forward 
Moderator(s) Ajay Israni (USA ), Sangho Lee (Korea)
10:50-11:20 Pre-OP Assessment and management of high risk patients Chan-Duck Kim (Korea) 
11:20-11:50 Immunologic monitoring after kidney transplantation: current status and future goal Natavudh Townamchai (Thailand) 
11:50-12:20 Immune suppression : Current approaches and future strategies Jong Soo Lee (Korea) 
 
10:50-12:20 Concurrent symposium 2 (Liver) Session Room 3, 2F 
Optimal Liver Transplantation strategies for the advanced HCC 
Moderator(s) Shin Hwang (Korea), Kwang-Woong Lee (Korea)
10:50-11:10 Selection criteria for LT beyond number and size of HCC - where are we? Alessandro Vitale (Italy) 
11:10-11:30 The role of radiation therapy and TARE for down-staging of advanced HCC before LT Do Young Kim (Korea) 
11:30-11:50 Technical consideration during recipient side operation for advanced HCC Kwang-Woong Lee (Korea) 
11:50-12:10 Post-transplant surveillance and appropriate immunosuppression strategy after LT for advanced HCC Dong Hwan Jung (Korea) 
 
10:50-12:20  Concurrent symposium 3 (Basic) Session Room 4, 2F 
Moderator(s) Tae Jin Kim (Korea), Wanli Liu (China)
10:50-11:20 The mechanism and application of aberrant B cell activation in autoimmune diseases Wanli Liu (China) 
11:20-11:50 Regulation of the alloimmune response by the IDO-AHR axis Su-Kil Seo (Korea) 
11:50-12:20 Bio-imaging for your preclinical study Seog Young Kim (Korea) 
 
12:20-12:40  KST General Assembly Session Room 2, 2F 
 
12:40-13:30  Luncheon symposium 3 (Astellas) Session Room 1, 1F 
Moderator(s) Chul Woo Yang (Korea), Kyung-Suk Suh (Korea)
12:40-13:30 Tacrolimus based immunosuppression - have we reached the summit? Nasrullah Undre (UK) 
 
12:40-13:30 Women in Transplantation Session Room 3, 2F 
Women in Transplantation 
Moderator(s) Hyeon Joo Jeong (Korea)
12:40-12:45 Introduction Hyeon Joo Jeong (Korea) 
12:45-13:15 Gender medicine in transplantation Hee Young Paik (Korea) 
13:15-13:20 Networking activity among female faculties (Yonsei Experience) Hyeon Joo Jeong (Korea) 
13:20-13:30 Discussion  
 
13:30-15:00  Oral presentation 1 (Kidney) Session Room 2, 2F 
Moderator(s) Yeong Hoon Kim (Korea), Hyung Joon Ahn (Korea)
13:30-13:40 Effect of Everolimus with Reduced-Exposure Calcineurin Inhibitor versus Mycophenolate with Standard-Exposure Calcineurin Inhibitor in Kidney Transplant Recipients from Asian Region: Subpopulation Analysis from the TRANSFORM Study Myoung Soo Kim (Korea) 
13:40-13:50 Outcomes of Dual Kidney Transplantation: Comparison to Single Kidney Transplantation From Standard and Expanded Criteria Donors. Kyo Won Lee (Korea) 
13:50-14:00 The predictors of acute kidney injury in deceased kidney donors after brain death Michal Wszola (Poland) 
14:00-14:10 "TRUST Trial: Timing of Removal for Ureteric Stents post-Transplant - early vs standard removal" Ryan Cha (New Zealand) 
14:10-14:20 Triglyceride to HDL-Cholesterol and risk of major cardiovascular events in renal transplantation recipients Ji Eun Kim (Korea) 
14:20-14:30 Outcomes of Organ Transplantation from Donors with Cancer History Shanzhou Huang (China) 
14:30-14:40 The Complete Chain of the First Global Kidney Exchange Transplant and Three-years Follow-up Siegfredo Paloyo (Philippines) 
14:40-14:50 Seroepidemiology and a randomized controlled study to determine the efficacy between the 2 and 3 doses of hepatitis A vaccine in Kidney Transplant Recipients Thaninee Prasoppokakorn (Thailand) 
 
13:30-15:00  Oral presentation 2 (Liver) Session Room 3, 2F 
Moderator(s) Deok-bog Moon (Korea), Dong Jin Joo (Korea)
13:30-13:40 Living Donor Liver Transplantation for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Jae Geun Lee (Korea) 
13:40-13:50 Outcomes of 50 cases of liver transplantation for intrapulmonary shunting Yoshihiro Hirata (Japan) 
13:50-14:00 Barring Stage 5 CKD in Living Donor Scenario Sequential and Simultaneous CLKT in CLD with CKD have comparable outcomes - Retrospective analysis of 2182 cases Naganathan Selvakumar (India) 
14:00-14:10 Favorable outcome of pathologic downstaging by the elimination of total necrosis based on the AJCC hepatocellular carcinoma staging after liver transplantation Deok Gie Kim (Korea) 
14:10-14:20 De novo Malignancies after Liver Transplantation and a proposal for establishment of cancer screening Kazuhiro Yoshida (Japan) 
14:20-14:30 East vs West: predictors of oncologic outcomes following DD and LD liver transplantation for HCC Jae Hyun Kwon (Korea) 
14:30-14:40 Dual Tracer PET-CT Predicted Tumour Biology and Recurrence after Liver Transplantation for HCC Kin Pan Au (Hong Kong) 
14:40-14:50 Clinical Course of Hepatic Artery Thrombosis after Living Donor Liver Transplantation using the Right Lobe Ho Joong Choi (Korea) 
14:50-15:00 Is tacrolimus the defendant of de novo food allergy following pediatric liver transplantation? Voranush Chongsrisawat (Thailand) 
 
13:30-15:00  Oral presentation 3 (Basic) Session Room 4, 2F 
Moderator(s) Junho Chung (Korea), Hyori Kim (Korea)
13:30-13:40 Complement 5 Inhibitor induced accommodation in murine ABO incompatible cardiac transplantation Jae-ghi Lee (Korea) 
13:40-13:50 Three-dimensional visualization of renal resident mononuclear cells with clearing in murine model of acute kidney injury Ju-Young Moon (Korea) 
13:50-14:00 Ischemic preconditioning ameliorates renal ischemia-reperfusion injury through activating the Nrf2/HO-1 pathway enhanced autophagy in Mice Jeongkye Hwang (Korea) 
14:00-14:10 Role of Human CD200 in Pig-to-Human Xenogeneic Immune Response in Tissue-Engineered Blood Vessel Ju Hee Hwang (Korea) 
14:10-14:20 Protective mechanism of Nitric oxide releasing nanofiber against renal ischemia-reperfusion injury in rat models. Hyun Min Ko (Korea) 
14:20-14:30 Biomarker candidate discovery for kidney allograft monitoring via urinary exosome proteome analysis Jee Yeon Kim (Korea) 
14:30-14:40 Immune Modulatory Effect of Thalidomide and Dexamethasone Co-treatment on Murine Splenocytes Eun Jee Kim (Korea) 
14:40-14:50 A new fluorescence imaging technique for visualizing hepatobiliary structures using sodium fluorescein: result of a preclinical study in a rat model Samyoul Yoon (Korea) 
 
15:00-16:00  Coffee break and Poster-oral presentation  
 
15:00-16:00  Poster-oral presentation 01 (Basic) Grand Ballroom, 3F 
Moderator(s) Tae Jin Kim (Korea), Seog Young Kim (Korea)
15:00-15:10 Substance P increases liver regeneration in Rat hepatectomy models. Hyun Min Ko (Korea) 
15:10-15:20 FK506 accelerates CoCl2 - induced cytotoxicity via ER stress pathway in HepG2 Cells Sang Young Chung (Korea) 
15:20-15:30 Integrin ¥áIIb¥â3 specific synthetic human monoclonal antibodies efficacy in platelet adhesion against porcine aortic endothelial cells (PAEC) Eun Mi Lee (Korea) 
15:30-15:40 The effect of prostaglandin E1 injected to donor in heterotopic rat heart transplantation model Minji Cho (Korea) 
15:40-15:50 Ulvan (sulfated polysaccharide) Pretreatment Ameliorates Hepatic Ischemia-Reperfusion Injury in Mice. Hyuk Jai Jang (Korea) 
 
15:00-16:00  Poster-oral presentation 02 (Kidney) Grand Ballroom, 3F 
Moderator(s) Young Hoon Kim (Korea), Kyung Hwan Jeong (Korea)
15:00-15:10 Development of a linear model for predicting recipient post-transplant serum creatinine after living donor kidney transplantation: A multicenter cross-validation study Jinsoo Rhu (Korea) 
15:10-15:20 En-bloc kidney transplantation from donors less than 15 kg: A single-center experience Kyong Ihn (Korea) 
15:20-15:30 TELE Clinic for Kidney Transplantation Patients Salin Wattanatorn (Thailand) 
15:30-15:40 Effects of rituximab dose on hepatitis B reactivation in patients with resolved infection undergoing immunologic incompatible kidney transplantation Juhan Lee (Korea) 
15:40-15:50 A Study of Pharmacokinetic Comparison between Generic Form and Original Form of Mycophenolate Mofetil in Renal Transplant Patients Nuttasith Larpparisuth (Thailand) 
 
15:00-16:00  Poster-oral presentation 03 (Kidney) Grand Ballroom, 3F 
Moderator(s) Dong Ryeol Lee (Korea), Jang-Hee Cho (Korea)
15:00-15:10 A Pilot Study Comparing the Efficacy, Safety and Switchability of Twice Daily Tacrolimus (Prograf) to Once Daily Tacrolimus (Advagraf) Among Standard Risk Kidney Transplant Patients in NKTI Romina Danguilan (Philippines) 
15:10-15:20 Should immunosuppression after kidney transplantation be adjusted based on renal resistance during pre-transplant hypothermic machine perfusion? Michal Wszola (Poland) 
15:20-15:30 ​Immediate Post-donation Hyperfiltration is associated with Decreased Functional Recovery in Living Kidney Donors Joon Chae Na (Korea) 
15:30-15:40 Dual induction with anti-thymocyte globulin and rituximab in sensitized kidney transplant patients. Hyukyong Kwon (Korea) 
15:40-15:50 Pretransplant osteoporosis and osteopenia are risk factors for fractures after kidney transplantation Eun Song Lee (Korea) 
15:50-16:00 Protective effect of alpha 1-antitrypsin on renal ischemia-reperfusion injury Kye Hwa Jeong (Korea) 
 
15:00-16:00  Poster-oral presentation 04 (Kidney) Grand Ballroom, 3F 
Moderator(s) Sung Shin (Korea), Jong Cheol Jeong (Korea)
15:00-15:10 PATIENT AND GRAFT OUTCOME AMONG FILIPINO POST-KIDNEY TRANSPLANT PREGNANCIES Feb Ian Alquiza (Philippines) 
15:10-15:20 Effect of kidney transplantation and arteriovenous fistula on cardiac load Sang Jun Park (Korea) 
15:20-15:30 Rituximab protects against early development of atherosclerotic cardiovascular disease after kidney transplantation Deok Gie Kim (Korea) 
15:30-15:40 Clinical outcomes of ABO incompatible kidney transplantation in single center. Kwon Cheol Yoo (Korea) 
15:40-15:50 Effect on Intra-patient Variability after Conversion from Twice-daily to Once-daily Tacrolimus in Thai Kidney Transplant Patients with and without CYP3A4 Inhibitors Nuttasith Larpparisuth (Thailand) 
15:50-16:00 Kidney Transplantation in Myanmar Military Hospitals / A Surgeon's perspective Than Aye (Myanmar) 
 
15:00-16:00  Poster-oral presentation 05 (Liver) Grand Ballroom, 3F 
Moderator(s) Say-June Kim (Korea), Junho Chung (Korea)
15:00-15:10 Combination of preservation fluid in cadaveric brain death donor can reduce cost of adult orthotopic liver transplantation Methee Sutherasan (Thailand) 
15:10-15:20 Circulating Bone Marrow-Derived Stem Cells and Serum Stem Cell Factor Levels in Patients with Hepatitis C Virus-Related Liver Disease: Relation to Hepatic Progenitor Cells and Hepatocyte Proliferation Hoda El Aggan (Egypt) 
15:20-15:30 Generation of well- preserved/ nanoparticle-crosslinked biocompatible acellular rat liver scaffold Ebtehal Ahmed (Korea) 
15:30-15:40 The effects of various immunosuppressants to EMT (in vitro and in vivo study). Berik Rovgaliyev (Korea) 
15:40-15:50 Outcomes of Living Donor Liver Transplantation for Patients with Preoperative Portal Vein Problems Ahmed Shehta (Egypt) 
15:50-16:00 The therapeutic potential of human liver-derived stem cells transplantation in a cirrhotic liver rat model JI-Hyun Lee (Korea) 
 
15:00-16:00  Poster-oral presentation 06 (Liver) Grand Ballroom, 3F 
Moderator(s) Je Ho Ryu (Korea), Doojin Kim (Korea)
15:00-15:10 Donor-Derived Cryptococcus Infection in Liver Transplant: A Rare Case Report WEN YAO YIN (Taiwan) 
15:10-15:20 Liver Transplantation for Chanarin-Dorfman Syndrome: a case report Aiymkul Ashimkhanova (Kazakhstan) 
15:20-15:30 Post-transplant lymphoproliferative disorder in children after liver transplantation Nataruks Chaijitraruch (Thailand) 
15:30-15:40 Impact of enterococcal bacteremia in liver transplant recipients Youn Jeong Kim (Korea) 
15:40-15:50 A Comparison Study: Fulminant Wilson's Disease vs. Acute Liver Failure in Children Yu Bin Kim (Korea) 
 
15:00-16:00  Poster-oral presentation 07 (Donation) Grand Ballroom, 3F 
Moderator(s) Hyung Hwan Moon (Korea), Hyoung Tae Kim (Korea)
15:00-15:10 Utilization of HbA1c in screening living kidney donors with prediabetes Joon Chae Na (Korea) 
15:10-15:20 The rate of potential brain death from medical record review by KODA Yongho Ju (Korea) 
15:20-15:30 Nomogram for predicting chronic kidney disease III for living donor nephrectomy Hyung Ho Lee (Korea) 
15:30-15:40 Prediction model of chronic kidney disease after donor nephrectomy in living kidney donors of postmenopausal women Jee Soo Park (Korea) 
15:40-15:50 Yearly trends of chronic kidney disease III progressions in living kidney donor Hyung Ho Lee (Korea) 
15:50-16:00 Survey for Effect of Mandatory Choice System about Organ donation after Brain Death in an Asian Country Young-nam Roh (Korea) 
 
16:00-17:00 Concurrent symposium 4 (Kidney) Session Room 1, 1F 
Kidney Transplantation in the Elderly : A step forward 
Moderator(s) Chang-kwon Oh (Korea), Anita S. Chong (USA )
16:00-16:20 Aging in kidney and immune system Hye Eun Yoon (Korea) 
16:20-16:40 Elderly donor issues : donor safety and graft survival Yoichi Kakuta (Japan) 
16:40-17:00 Elderly recipeints : Important issues in clinical practice Beom Seok Kim (Korea) 
 
16:00-17:00 Concurrent symposium 5 (Liver) Session Room 2, 2F 
Selection and management of the high-risk donor in LDLT & DDLT 
Moderator(s) Myoung Soo Kim (Korea), Chandra Bhati (India)
16:00-16:15 Expanding donor pool from elderly donors Dong Jin Joo (Korea) 
16:15-16:30 Use of liver graft form donors with hepatitis B & C Jong Young Choi (Korea) 
16:30-16:45 Impact of steatosis on the outcome of liver transplantation Hideki Ohdan (Japan) 
16:45-17:00 LT using donation after circulatory death Chandra Bhati (USA) 
 
16:00-17:00 Concurrent symposium 6 (Pancreas) Session Room 3, 2F 
Islet transplantation : A step forward 
Moderator(s) Krishan Lal Gupta (India), Sungjoo Kim (Korea)
16:00-16:20 Encapsulated islet transplantation Jonathan RT Lakey (USA ) 
16:20-16:40 Xeno-islet transplantation Jun-Seop Shin (Korea) 
16:40-17:00 Allo-islet transplantation Jae Hyeon Kim (Korea) 
 
17:00-18:00  Oral presentation 4 (Kidney) Session Room 1, 1F 
Moderator(s) Jong Soo Lee (Korea), Man Ki Ju (Korea)
17:00-17:10 Short- and Intermediate-Term Outcomes of Living Kidney Donation: From the Standpoint of Donor Muhammad Tassaduq Khan (Pakistan) 
17:10-17:20 Low-dose in situ perfusion with Euro-Collins solution is effective for the procurement of marginal kidney grafts from donation after circulatory death donors Tamotsu Tojimbara (Japan) 
17:20-17:30 Investigation of pulse pressure, systolic blood pressure, and diastolic blood pressure in living kidney donors after donor nephrectomy Jee Soo Park (Korea) 
17:30-17:40 Investigations of living donor nephrectomy on mineral metabolism in postmenopausal Asian women Jee Soo Park (Korea) 
17:40-17:50 OUTCOME OF LIVING KIDNEY DONORS AT THE NATIONAL KIDNEY AND TRANSPLANT INSTITUTE Romina Danguilan (Philippines) 
17:50-18:00 Suitable Candidates for Expanded Criteria Donor Kidney Transplantation in Korea Tai Yeon Koo (Korea) 
 
17:00-18:00  Oral presentation 5 (Liver) Session Room 2, 2F 
Moderator(s) Kenneth Chok (Hong Kong), Myunghee Yoon (Korea)
17:00-17:10 Immune Markers Indicating Tolerance for Tapering Immunosuppression after Liver Transplantation: A Prospective Study Soon Kyu Lee (Korea) 
17:10-17:20 The First Series of Ischemia-free Liver Transplantation in Human Xiaoshun He (China) 
17:20-17:30 Impacts of FoxP3 gene polymorphisms on immunological features of HBV-related liver transplant recipients Yuka Tanaka (Japan) 
17:30-17:40 Left Is Right, A Win-win Situation in Living Donor Liver Transplantation Ka Wing Ma  
17:40-17:50 The practical use of cell-free and concentrated ascites reinfusion therapy (KM-CART) for the liver transplant recipients with perioperative refractory ascites Seiichi Shimizu (Japan) 
 
17:00-18:00  Concurrent symposium 7 (Xenotransplantation) Session Room 3, 2F 
Moderator(s) Nam-Hyung Kim (Korea), Curie Ahn (Korea)
17:00-17:20 Targeting ABMR: From bench to bedside Anita S. Chong (USA ) 
17:20-17:40 The role of Memory Tregs in acquired tolerance to Islet Xenografts Philip O'Connell (Australia) 
17:40-18:00 Organogenesis Using human organoids Eiji Kobayashi (Japan) 
 
17:00-18:00  Oral presentation 6 (Others/Pancreas/Islet) Session Room 4, 2F 
Moderator(s) Jae Berm Park (Korea), Young Hoon Kim (Korea)
17:00-17:10 Outcomes of Combined Liver and Pancreas Transplantation: A Review of the SRTR National Database and a Report of the Largest Single Center Series Wei Zhang (China) 
17:10-17:20 Islat autotransplantation in diabetic patients. Andrzej Berman (Poland) 
17:20-17:30 Do we need insulin independence after islet transplantation? Andrzej Berman (Poland) 
17:30-17:40 The Incidence of Posttransplantation Diabetes Mellitus Within 1-Year after Kidney Transplantation and Related Factors in Korean cohort study Jin Hyuk Paek (Korea) 
17:40-17:50 The comparison of glycemic profiles during post-operative early period between liver and kidney transplantation assessed by continuous glucose monitoring system (CGMS) Hong Pil Hwang (Korea) 
17:50-18:00 Changes in gene expression of selected genes in patient with type 1 diabetes in peripheral blood Michal Wszola (Poland) 
 
18:00-20:00  Welcome Reception Convention Hall Foyer, 2F, Bexco 
 
08:00-09:30 Concurrent symposium 8 (Kidney) Session Room 2, 2F 
Management of failed graft (KSN joint symposium) 
Moderator(s) Chul-Woo Yang (Korea), Stanley Jordan (USA )
08:00-08:30 Weaning of immunosuppressive drugs after graft failure Jung Pyo Lee (Korea) 
08:30-09:00 Graft intolerance syndrome: embolization versus surgical removal Sun Cheol Park (Korea) 
09:00-09:30 In or out of failed graft. Which one is better for retransplantation? Myung-gyu Kim (Korea) 
 
08:00-09:30  KOTRY Joint session Session Room 3, 2F 
Moderator(s) Curie Ahn (Korea), Myoung Soo Kim (Korea)
08:00-08:30 Using Big Data to Impact Patient Care and Policy Dorry Segev (USA ) 
08:30-09:00 Move to Patient Centered Report Cards for Precision Medicine in Transplantation in the United States. Ajay Israni (USA ) 
09:00-09:30 Layers and Dimensions in KOTRY: Introduction of ingredients and invitation for future recipes. Jong Cheol Jeong (Korea) 
 
08:00-09:30 Concurrent symposium 9 (Lung) Session Room 4, 2F 
Peri lung transplant care 
Moderator(s) Young Tae Kim (Korea), Moo Suk Park (Korea)
08:00-08:20 Pre and post immunosuppressant Balasubramani Govini (India) 
08:20-08:40 Peri lung transplant rehabilitation Sangbum Hong (Korea) 
08:40-09:00 Post transplant follow up strategy Kyeongman Jeon (Korea) 
09:00-09:20 Peri transplant Infection Wan Beom Park (Korea) 
09:20-09:30 Panel discussion Do Hyung Kim (Korea)
Sangbum Hong (Korea)
Sunmi Choi (Korea)
(Korea)
 
 
09:30-10:30  Concurrent symposium 10 (Anesthesia) Session Room 2, 2F 
Moderator(s) Do Hyung Kim (Korea), Gaab Soo Kim (Korea)
09:30-09:45 Anesthetic considerations for liver transplantation Kyeo-woon Jung (Korea) 
09:45-10:00 Anesthetic considerations for heart transplantation Yunseok Jeon (Korea) 
10:00-10:15 Anesthetic considerations for lung transplantation Hee Young Kim (Korea) 
10:15-10:30 Anesthetic considerations for kidney transplantation Sang Hyun Lee (Korea) 
 
09:30-10:30  Oral presentation 7 - Video Session Room 3, 2F 
Moderator(s) Koo Jeong Kang (Korea), Young Kyoung You (Korea)
09:30-09:40 LIVING DONOR LIVER TRANSPLANTATION FOR ABERNETHY MALFORMATION Kumar Palaniappan (India) 
09:40-09:50 Right anterior sector graft for living donor liver transplantation Jonathan Navarro (Philippines) 
09:50-10:00 The future: Ischemic-less robot hybrid operation for transplantation. Jin Go (Korea) 
10:00-10:10 First case of Domino living donor liver transplantation in Korea Jong Man Kim (Korea) 
10:10-10:20 LIVING DONOR LIVER TRANSPLANTATION FOR BUDD-CHIARI SYNDROME WITH THROMBOSED VENA CAVA Kumar Palaniappan (India) 
10:20-10:30 LIVING DONOR LIVER TRANSPLANTATION FOR LEIOMYOSARCOMA OF IVC CAUSING ACUTE BUDD-CHIARI SYNDROME Kumar Palaniappan (India) 
 
09:30-10:30 Concurrent symposium 11 (Heart) Session Room 4, 2F 
Issues in heart transplantation  
Moderator(s) Jae-Jung Kim (Korea), Nam Hee Park (Korea)
09:30-09:45 Broadening donor heart: Donation after circulatory death/Utilization of marginal donor Sung Ho Jung (Korea) 
09:45-10:00 Long term results of donor/recipient gender mismatch Jaewon Oh (Korea) 
10:00-10:15 Heart transplantation in Japan Norihide Fukushima (Japan) 
10:15-10:30 Panel discussion In-Cheol Kim(Korea)
Min Ho Ju (Korea) (Korea)
 
 
10:30-11:30  Coffee break and Poster-oral presentation  
 
10:30-11:30  Poster-oral presentation 08 (Thoracic) Grand Ballroom, 3F 
Moderator(s) Sung Ho Jung (Korea), Hyo Chae Paik (Korea)
10:30-10:40 A case of heart transplantation from a donor with atrial septal defect secondum Hye Won Lee (Korea) 
10:40-10:50 An experience of induction with rabbit anti-thymocyte globulin in heart transplantation Hye Won Lee (Korea) 
10:50-11:00 Left ventricular assist device and heart transplantation for adult congenital heart disease: Single center experiences Koichi Toda (Korea) 
11:00-11:10 Long-term outcomes of lung transplantation in South Korea: A single-center study Geun Dong Lee (Korea) 
 
10:30-11:30  Poster-oral presentation 09 (Kidney) Grand Ballroom, 3F 
Moderator(s) Sang Heon Song (Korea), Sunwoo Kang (Korea)
10:30-10:40 Changes in health-related quality of life in kidney transplant patients over time compared with those in chronic kidney disease patients JungHwa Ryu (Korea) 
10:40-10:50 Efficacy and Safety of Ultra-Low dose Valganciclovir Chemoprophylaxis for CMV infection in High risk KTP Jin Ho Lee (Korea) 
10:50-11:00 Clinical Outcomes of Latent Tuberculosis Infection in Living Donor Kidney Transplant Recipients Tae Hyun Ban (Korea) 
11:00-11:10 Impact of infectious complications on antibody-mediated rejection after ABO-incompatible kidney transplantations Hyunwook Kwon (Korea) 
11:10-11:20 The preventive role of mTOR inhibitor in post kidney transplantation urothelial carcinoma Yin Lun Chang (Taiwan) 
11:20-11:30 THERAPEUTIC DRUG MONITORING OF CYCLOSPORINE AND TACROLIMUS IN MYANMAR KIDNEY TRANSPLANT PATIENTS Yi Yi Htun (Myanmar) 
 
10:30-11:30  Poster-oral presentation 10 (Kidney) Grand Ballroom, 3F 
Moderator(s) Borae G Park (Korea), Hee Gyung Kang (Korea)
10:30-10:40 Kidney Transplant Outcomes in Recipients with Physical Disabilities Dorry Segev (United States) 
10:40-10:50 Frailty and Access to Kidney Transplantation Dorry Segev (United States) 
10:50-11:00 The availability of Protocol allograft biopsy and De novo donor specific antibody monitoring after kidney transplantation Sua Lee (Korea) 
11:00-11:10 Targeting class I histone deacetylase in renal tubular epithelial cells inhibits priming inflammatory responses Sunwoo Kang (Korea) 
11:10-11:20 Isolated Small bowel Transplantation for managing the "no gut syndrome" without bridging bowel continuity operation - A case report Jeongkye Hwang (Korea) 
 
10:30-11:30  Poster-oral presentation 11 (Liver) Grand Ballroom, 3F 
Moderator(s) Dong Hwan Jung (Korea), Tin Tin Mar (Myanmar)
10:30-10:40 COMPARATIVE STUDY OF BILLIARY COMPLICATIONS IN LIVER TRANSPLANTATION DEVELOPING COUNTRIES Batsaikhan Batsuuri (Mongolia) 
10:40-10:50 Late-onset acute rejection may contribute to poor outcomes in adolescence and young adulthood in liver transplantation. Masahiro Takeda (Japan) 
10:50-11:00 Incidence and risk factors for alcohol relapse after liver transplantation for alcoholic liver disease: Comparison between living donor and deceased donor liver transplantation Hye Gyo Chung (Korea) 
11:00-11:10 Long-term influence of CYP3A5 gene polymorphisms of donor and recipient of liver transplantation Nayoung Han (Korea) 
 
10:30-11:30  Poster-oral presentation 12 (Liver) Grand Ballroom, 3F 
Moderator(s) Geun Hong (Korea), Tae-Seok Kim (Korea)
10:30-10:40 Live donor liver transplantation in National Cancer Center of Mongolia: a report on the first 4 cases Munkhbat Radnaabazar (Mongolia) 
10:40-10:50 Liver Transplantation in Portopulmonary Hypertension with End Stage Liver Disease: First Case in Myanmmar Chan Min Thwin (Myanmar) 
10:50-11:00 The Adult-to-Adult Living Donor Liver Transplantation: Postoperative Outcome and Quality of Life in Liver Donors: the First Report in Thailand Kanya Udomsin (Thailand) 
11:00-11:10 EFFECT OF VENA CAVAL BLOOD VENTING AFTER REPERFUSION ON EARLY LIVER TRANSPLANTATION OUTCOME Nasir Fakhar (Iran) 
 
10:30-11:30  Poster-oral presentation 13 (Others) Grand Ballroom, 3F 
Moderator(s) Myung-gyu Kim (Korea), Jin Gu Lee (Korea)
10:30-10:40 Cytomegalovirus (CMV)-ELISPOT and lymphocyte subset analysis at post-transplant 1 month to predict CMV infection in seropositive kidney transplant recipients Ki Hyun Park (Korea) 
10:40-10:50 How panel reactive antibody and donor specific antibody before lung transplantation can affect the outcome in Korean lung transplanted-population Sungwoo Moon (Korea) 
10:50-11:00 The Characteristics of Long-term Cytomegalovirus Non-reactivators in Seropositive Lung Transplant Recipients SANG HOON HAN (Korea) 
11:00-11:10 Effect of Donation improvement program(DIP) on each step strategy of donation SuJin Heo (Korea) 
11:20-11:30 RECONSTITUTED TRACHEA FROM THE SKIN FLAP AND CARTILAGE ITSELF IN THE EXPERIMENTAL LUNG TRANSPLANT Do Xuan Hai (Vietnam) 
 
10:30-11:30  Poster-oral presentation 14 (Coordinator) Grand Ballroom, 3F 
Moderator(s) Kyung Ock Jeon (Korea), Jeong Rim Lee (Korea)
10:30-10:40 Reasons for Rejection and Discontinuance of Tissue Donation in Korea Oh Hyuk Yun (Korea) 
10:40-10:50 Pregnancy after heart transplant In Ok Kim (Korea) 
10:50-11:00 Reasons of consent for organ donation Eunji Lee (Korea) 
11:00-11:10 Causes of Rejection for Organ Donation by Family of Deceased Donor Myounghwa Lee (Korea) 
11:10-11:20 Selection of liver graft from deceased donors using shore durometer Sora Cha (Korea) 
11:20-11:30 Demographic findings of foreign donors in Korea Chunhee Bok (Korea) 
 
11:30-12:30  Keynote lectures 2 Session Room 1, 1F 
Moderator(s) Jae-Jung Kim (Korea), Chul-Woo Yang (Korea)
11:30-12:00 Strategies of advanced heart failure in Japan: Left ventricular assist device and heart transplantation Norihide Fukushima (Japan) 
12:00-12:30 Lessons from recent genowide study in kidney transplantation and future directions Ajay Israni (USA ) 
 
12:30-13:30  Luncheon symposium 4 (Chong Kun Dang Pharm.) Session Room 2, 2F 
Moderator(s) Yu Seun Kim (Korea)
12:30-13:00 The Effects of Conversion from Cyclosporine to Tacrolimus on the Changes of Cardiovascular Risk Profiles and Serum Metabolites in Renal Transplant Recipients Jang-Hee Cho (Korea) 
Moderator(s) Kyung-Suk Suh (Korea)
13:00-13:30 My-Rept¢ç in Combination with Tacrolimus in Liver Transplantation Tablet versus Capsule of Mycophenolate Mofetil Jong Man Kim (Korea) 
 
12:30-13:30  Luncheon symposium 5 (Novartis Korea) Session Room 3, 2F 
Moderator(s) Jae-Won Joh (Korea)
12:30-13:30 The role of Everolimus in liver transplantation; our expectations and reality Dong Jin Joo (Korea) 
 
12:30-13:30  Luncheon symposium 6 (Roche Korea) Session Room 4, 2F 
Moderator(s) Duck-Jong Han (Korea), Joong-Kyung Kim (Korea)
12:30-13:30 Pre-&Post-Transplant Anemia Management Jaeseok Yang (Korea) 
 
13:30-14:30  Plenary session 2 Session Room 1, 1F 
Moderator(s) Curie Ahn (Korea), Jeremy Chapman (Australia)
13:30-14:00 IgG Endopeptidase in Highly Sensitized Patients Stanley Jordan (USA ) 
14:00-14:30 Investigating the behaviors of T cell and B cell subsets in transplantation tolerance and rejection Anita S. Chong (USA ) 
 
14:30-15:00  Coffee break  
 
15:00-16:00  Concurrent symposium 12 - Coordination Session Room 2, 2F 
Moderator(s) Bok Nyeo Kim (Korea), Ok Kyung Kim (Korea)
15:00-15:20 The work environment of transplant coordinator In Ok Kim (Korea) 
15:20-15:40 The labor standard act and the work of transplant coordinator Hyung Sook Kim (Korea) 
15:40-15:50 Q & A -  
15:50-16:00 Assembly In Ok Kim (Korea) 
 
15:00-16:00 Concurrent symposium 13 (Liver) Session Room 3, 2F 
Refinements on the surgical techniques in liver transplantation (Video) 
Moderator(s) Kyung-Suk Suh (Korea), Mohamed Rela (India)
15:00-15:10 Living donor hepatectomy (Open & Laparoscopy) Gyu-seong Choi (Korea) 
15:10-15:20 Engraftment in LDLT Mohamed Rela (India) 
15:20-15:30 Engraftment in DDLT Deok-bog Moon (Korea) 
15:30-15:40 Biliary reconstruction Wei-Chen Lee (Taiwan) 
15:40-15:50 Vascular reconstruction in pediatric LT Jung-Man Namgoong (Korea) 
 
15:00-16:00 Oral presentation 8 (Heart/Lung) Session Room 4, 2F 
Thoracic session 
Moderator(s) Jae-Jung Kim (Korea), Jin Gu Lee (Korea)
15:00-15:10 Prevalence of Donor-Transmitted Coronary Artery Disease and Its Impact on Long-Term Prognosis Ho Hyun Ko (Korea) 
15:10-15:20 Impact of bridge to bridge strategies on the pre and post heart transplant outcome in the era of implantable ventricular assist device: A single-center experience Seiko Nakajima (Japan) 
15:20-15:30 Risk factors for cytomegalovirus (CMV) reactivation in lung transplant recipients Sehyun Kwak (Korea) 
15:30-15:40 Lung transplantation after bridge with extracorporeal membrane oxygenation: Analysis of Korean Organ Transplantation Registry (KOTRY) data Ryoung-Eun Ko (Korea) 
15:40-15:50 Incidence and risk factors for acute kidney injury after lung transplantation: A single Korean center NamEun Kim (Korea) 
 
16:00-17:00  Oral presentation 9 - Coordinatior Session Room 2, 2F 
Moderator(s) Seung Heui Hong (Korea), Sook Seong (Korea)
 
16:00-17:00 Oral presentation 9 - Coordinator Session Room 4, 2F 
TBD 
16:00-16:12 Development of Audiovisual Patient Education Material for Lung Transplant Candidates Anes Kim (Korea) 
16:12-16:24 ½ÅÀÌ½Ä È¯ÀÚÀÇ È¯ÀÚ±³À°¿ä±¸¿¡ µû¸¥ µ¿¿µ»ó ±³À°ÀÚ·á °³¹ß Sunyoung Son (Korea) 
16:24-16:36 Àå±âÀ̽ÄÄÚµð³×ÀÌÅÍÀÇ °¨Á¤³ëµ¿¿¡ µû¸¥ Á÷¹«¼ÒÁø, ÁöÁöü°è, Á÷¹«½ºÆ®·¹½º ȸº¹°æÇè ÇöȲ Á¶»ç Ok-kyung Kim (Korea) 
16:36-16:48 Causes of failure during the management process from identification of brain-dead potential organ donors to actual donation in Korea Miim Kim (Korea) 
16:48-17:00 Analysis of clinical outcomes according to definition of slow graft function in deceased donor kidney transplantation GeunHee Kim (Korea) 
 
16:00-17:00  Oral presentation 10 (Liver) Session Room 3, 2F 
Moderator(s) Soon-il Kim (Korea), Mureo Kasahara (Japan)
16:00-16:10 Renal function between Tenofovir and Entecavir in post-liver transplant hepatitis B patients Sang Jin Kim (Korea) 
16:10-16:20 Guideline for optimal port system in pure 3D laparoscopic donor Right hemihepatectomy Jeong-Moo Lee (Korea) 
16:20-16:30 Outcomes after HIV+ to HIV+ Liver Transplantation: A National Study in the United States Dorry Segev (United States) 
16:30-16:40 Individualized optimization of prophylaxis with hepatitis B Immunoglobulin using pharmacokinetic half-life simulation after liver transplantation Shin Hwang (Korea) 
16:40-16:50 Da Vinci Robot-assisted living donor right hepatectomy Seoung Yoon Rho (Korea) 
 
16:00-17:00  Oral presentation 11 (Kidney) Session Room 4, 2F 
Moderator(s) Chan-Duck Kim (Korea), Soo Jin Na Choi (Korea)
16:00-16:10 Anti-CD45RB Attenuated Renal Ischemia-Reperfusion Injury by Induction of Regulatory B Cells Taishi Fang (Korea) 
16:10-16:20 Improve diagnosis of BK infection by TGF-b and avoid rejection by activated T cells in renal transplant patients. Wen Yao Yin (Taiwan) 
16:20-16:30 Urinary exosomal microRNA as a non-invasive biomarker for the diagnosis of acute rejection in kidney transplant recipients Su Woong Jung (Korea) 
16:30-16:40 The study of TWEAK/Fn14 and inflammatory cytokines in progressive renal graft dysfunction Cheng-Hsu Chen (Taiwan) 
16:40-16:50 The Balance Between Interleukin 17-Secreting T Helper Cells And Regulatory T Cells After Renal Transplantation: Relation to Graft Function and Survival Hayam El Aggan (Egypt) 
16:50-17:00 Granulocyte-colony stimulating factor ameliorates renal ischemia-reperfusion injury by recruiting myeloid-derived suppressor cells to kidney Ji-Jing Yan (Korea) 
 
17:00-18:00  Award ceremony and closing Session Room 2, 2F